4//SEC Filing
Gross Jeffrey M 4
Accession 0001096481-11-000005
CIK 0001096481other
Filed
May 15, 8:00 PM ET
Accepted
May 16, 5:47 PM ET
Size
21.7 KB
Accession
0001096481-11-000005
Insider Transaction Report
Form 4
Gross Jeffrey M
SVP, Research & Development
Transactions
- Other
Common Stock
2009-08-27$1.68/sh−6,000$10,080→ 36,000 total - Other
Stock Option w/Tandem SAR
2008-10-20−25,000→ 0 totalExercise: $7.61From: 2007-08-01Exp: 2012-07-02→ Common Stock (25,000 underlying) - Other
Stock Option w/Tandem SAR
2008-12-08−100,000→ 25,000 totalExercise: $0.21From: 2009-01-01Exp: 2013-12-07→ Common Stock (100,000 underlying) - Other
Common Stock
2009-08-14$1.72/sh−1,500$2,580→ 34,500 total - Other
Common Stock
2009-06-17$1.85/sh−12,500$23,125→ 0 total - Other
Common Stock
2010-03-26$1.11/sh−9,000$9,990→ 42,000 total - Other
Common Stock
2009-08-13$1.80/sh−2,000$3,600→ 32,500 total - Other
Stock Option w/Tandem SAR
2009-03-10−150,000→ 125,000 totalExercise: $0.38From: 2009-04-01Exp: 2014-03-09→ Common Stock (150,000 underlying) - Other
Common Stock
2009-06-22$1.77/sh−20,000$35,400→ 12,500 total - Other
Stock Option w/Tandem SAR
2010-03-08−85,000→ 275,000 totalExercise: $1.09From: 2010-04-01Exp: 2015-03-07→ Common Stock (85,000 underlying)
Footnotes (2)
- [F1]Effective on May 12, 2011, all of the Company's existing common shares and options to acquire common shares were canceled without any payment or consideration therefor, in connection with the implementation of a plan of compromise or arrangement under the Companies' Creditors Arrangement Act (Canada).
- [F2]Price is in Canadian $.
Documents
Issuer
ANGIOTECH PHARMACEUTICALS INC
CIK 0001096481
Entity typeother
Related Parties
1- filerCIK 0001448731
Filing Metadata
- Form type
- 4
- Filed
- May 15, 8:00 PM ET
- Accepted
- May 16, 5:47 PM ET
- Size
- 21.7 KB